Serotonin Uptake Inhibitors
"Serotonin Uptake Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that specifically inhibit the reuptake of serotonin in the brain.
| Descriptor ID |
D017367
|
| MeSH Number(s) |
D27.505.519.562.437.850 D27.505.519.625.600.850 D27.505.519.625.850.900 D27.505.696.577.600.850 D27.505.696.577.850.900
|
| Concept/Terms |
Serotonin Uptake Inhibitors- Serotonin Uptake Inhibitors
- 5-Hydroxytryptamine Uptake Inhibitors
- 5 Hydroxytryptamine Uptake Inhibitors
- Inhibitors, 5-HT Uptake
- Inhibitors, 5 HT Uptake
- Inhibitors, 5-Hydroxytryptamine Uptake
- Inhibitors, 5 Hydroxytryptamine Uptake
- Inhibitors, Serotonin Reuptake
- Reuptake Inhibitors, Serotonin
- Serotonin Reuptake Inhibitors
- Uptake Inhibitors, 5-HT
- Uptake Inhibitors, 5 HT
- Uptake Inhibitors, 5-Hydroxytryptamine
- Uptake Inhibitors, 5 Hydroxytryptamine
- Uptake Inhibitors, Serotonin
- 5-HT Uptake Inhibitors
- 5 HT Uptake Inhibitors
- Inhibitors, Serotonin Uptake
|
Below are MeSH descriptors whose meaning is more general than "Serotonin Uptake Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Serotonin Uptake Inhibitors".
This graph shows the total number of publications written about "Serotonin Uptake Inhibitors" by people in this website by year, and whether "Serotonin Uptake Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2005 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 2 | 0 | 2 |
| 2016 | 1 | 2 | 3 |
| 2017 | 12 | 8 | 20 |
| 2018 | 15 | 8 | 23 |
| 2019 | 11 | 5 | 16 |
To return to the timeline, click here.
Below are the most recent publications written about "Serotonin Uptake Inhibitors" by people in Profiles.
-
Obsessive Compulsive Disorder During Coronavirus Disease 2019 (COVID-19): 2- and 6-Month Follow-Ups in a Clinical Trial. Int J Neuropsychopharmacol. 2021 09 21; 24(9):703-709.
-
SSRIs: Applications in inflammatory lung disease and implications for COVID-19. Neuropsychopharmacol Rep. 2021 09; 41(3):325-335.
-
Defining and Addressing Gaps in Care for Obsessive-Compulsive Disorder in the United States. Psychiatr Serv. 2021 07 01; 72(7):784-793.
-
Moderation of the transgenerational transference of antenatal stress-induced anxiety. Transl Psychiatry. 2021 05 04; 11(1):268.
-
Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives? J Clin Neurosci. 2021 Jun; 88:163-172.
-
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue. Sci Rep. 2021 03 15; 11(1):5890.
-
Are central nervous system drugs displaying anti-inflammatory activity suitable for early treatment of COVID-19? Folia Neuropathol. 2021; 59(2):113-120.
-
Discontinuation Syndrome of Extended-Release Venlafaxine during the COVID-19 Epidemic. Psychiatr Danub. 2021; 33(1):121-122.
-
Prolonged treatment of COVID-19 pneumonia with high-flow nasal oxygen: A story of oxygen and resilience. S Afr Med J. 2020 10 08; 110(12):1168-1171.
-
Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19? Eur J Pharmacol. 2020 Dec 15; 889:173629.